Cannabics Pharmaceuticals changes name to CNBX Pharmaceuticals, ticker unchanged

CNBX Pharmaceuticals Inc.

Name change effective March 28, 2022; stock continues trading on OTCQB under symbol CNBX.
Name change reflects transformation to molecule-based drug development for colorectal cancer treatment.
Company preparing Phase I/II clinical validation study for proprietary RCC-33 drug candidate.
Stockholders need not exchange certificates; rights unaffected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.